What does Mankind Pharma do?

Jun 06 2025 06:19 PM IST
share
Share Via
Mankind Pharma Ltd is a large-cap pharmaceutical company, incorporated in 1991, with net sales of ₹3,079 Cr and a net profit of ₹421 Cr for the quarter ending March 2025. It has a market cap of ₹97,159 Cr and a P/E ratio of 49.00.
Overview:
Mankind Pharma Ltd is a large-cap company operating in the Pharmaceuticals & Biotechnology industry.

History:
Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company and was converted to a Public Limited Company on July 14, 2005. The latest quarterly results report net sales and profit for the period ending March 2025.

Financial Snapshot:
- Net Sales: 3,079 Cr (Quarterly Results - Mar 2025)
- Net Profit: 421 Cr (Quarterly Results - Mar 2025)
- Market Cap: Rs 97,159 Cr (Large Cap)

Key Metrics:
- P/E: 49.00
- Industry P/E: 35
- Dividend Yield: 0.00%
- Debt-Equity: -0.40
- Return on Equity: 20.02%
- Price to Book: 9.22

Contact Details:
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News